Samsung Pharmaceutical

001360 · KOSPI · Health Care · SMALL CAP

Material event report (CB call option holder designated)

Capital raise(Material event report (CB call option holder designated))· FILED 2026-01-16· RCEPT 20260116000431

About this filing

Concerns a call option on the company's convertible bonds: the right to buy the bonds back from holders, and who is designated to exercise it (often the largest shareholder or a related party).

Why companies file it: Who holds or exercises the call option matters because the bonds can turn into shares.

A full English translation of this filing is not available yet. The original (in Korean) is linked below.

Filed2026-01-16, Material event report (CB call option holder designated)
SourceDART rcept 20260116000431 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-01-16 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).